Developmental programming: Impact of excess prenatal testosterone on intrauterine fetal endocrine milieu and growth in sheep

Biology of Reproduction

Volumn 84, Issue 1, 2011, Pages 87-96

  Veiga Lopez, Almudena ^a   Steckler, Teresa L ^a,f   Abbott, David H ^b   Welch, Kathleen B ^c   MohanKumar, Puliyur S ^d   Phillips, David J ^e   Refsal, Kent ^d   Padmanabhan, Vasantha ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

^e MONASH UNIVERSITY   (Australia)

^f UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Activin; Androgens; Developmental biology; Estrogens; PCOS

Indexed keywords

COTTON SEED OIL; ESTROGEN; TESTOSTERONE; TESTOSTERONE PROPIONATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; INTRAUTERINE GROWTH RETARDATION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; PREGNANCY; PRENATAL PERIOD; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SHEEP;

ANIMALS; BLOOD GLUCOSE; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; INSULIN; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SHEEP; TESTOSTERONE PROPIONATE; THYROXINE; TRIIODOTHYRONINE;

MICROPUS; OVIS ARIES;

EID: 78649864843     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.110.086686     Document Type: Article

References (80)

1. Fowden AL, Giussani DA, Forhead AJ. Intrauterine programming of physiological systems: Causes and consequences. Physiology (Bethesda) 2006; 21:29-37.
2. Murphy VE, Smith R, Giles WB, Clifton VL. Endocrine regulation of human fetal growth: The role of the mother, placenta, and fetus. Endocr Rev 2006; 27:141-169.
3. Abbott DH, Dumesic DA, Levine JE, Dunaif A, Padmanabhan V. Animal models and fetal programming of PCOS. In: Azziz JE, Nestler JE, Dewailly D (eds.), Contemporary Endocrinology: Androgen Excess Disorders in Women: Polycystic Ovary Syndrome and Other Disorders, 2nd ed. Totowa, NJ: Humana Press Inc.; 2006:259-272.
4. Padmanabhan V, Sarma HN, Savabieasfahani M, Steckler TL, Veiga- Lopez A. Developmental reprogramming of reproductive and metabolic dysfunction in sheep: Native steroids vs. environmental steroid receptor modulators. Int J Androl 2010; 33:394-404.
5. Padmanabhan V, Veiga-Lopez A, Abbott DH, Recabarren SE, Herkimer C. Developmental programming: Impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight females. Endocrinology 2010; 151:595-605.
6. Recabarren SE, Padmanabhan V, Codner E, Lobos A, Duran C, Vidal M, Foster DL, Sir-Petermann T. Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone. Am J Physiol Endocrinol Metab 2005; 289:E801-E806.
7. Abbott DH, Bruns CM, Barnett DK, Tarantal AF, Hoffmann SM, Zhou R, Levine JE, Dumesic DA. Fetal origins of the polycystic ovarian syndrome. In: Dunaif A, Chang RJ, Franks S, Legro RS (eds.), Polycystic Ovarian Syndrome, 1st ed. Totowa, NJ: Humana Press; 2008:87-106.
8. Ehrmann DA. Insulin resistance and polycystic ovary syndrome. Curr Diab Rep 2002; 2:71-76.
9. Marshall JC, Eagleson CA. Neuroendocrine aspects of polycystic ovary syndrome. Endocrinol Metab Clin North Am 1999; 28:295-324.
10. Franks S, Stark J, Hardy K. Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update 2008; 14:367-378. (Pubitemid 351858976)
11. Veiga-Lopez A, Astapova OI, Aizenberg EF, Lee JS, Padmanabhan V. Developmental programming: Contribution of prenatal androgen and estrogen to estradiol feedback systems and periovulatory hormonal dynamics in sheep. Biol Reprod 2009; 80:718-725.
12. Steckler T, Manikkam M, Inskeep EK, Padmanabhan V. Developmental programming: Follicular persistence in prenatal testosterone-treated sheep is not programmed by androgenic actions of testosterone. Endocrinology 2007; 148:3532-3540.
13. Smith P, Steckler TL, Veiga-Lopez A, Padmanabhan V. Developmental programming: Differential effects of prenatal testosterone and dihydrotestosterone on follicular recruitment, depletion of follicular reserve, and ovarian morphology in sheep. Biol Reprod 2009; 80:726-736.
14. Jackson LM, Timmer KM, Foster DL. Sexual differentiation of the external genitalia and the timing of puberty in the presence of an antiandrogen in sheep. Endocrinology 2008; 149:4200-4208.
15. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008; 359:61-73.
16. Barker DJP. Mothers, Babies, and Disease in Later Life. London: BMJ Publishing Group; 1994.
17. Dodic M, Abouantoun T, O'Connor A, Wintour EM, Moritz KM. Programming effects of short prenatal exposure to dexamethasone in sheep. Hypertension 2002; 40:729-734. (Pubitemid 35278611)
18. Hemmings DG, Williams SJ, Davidge ST. Increased myogenic tone in 7- month-old adult male but not female offspring from rat dams exposed to hypoxia during pregnancy. Am J Physiol Heart Circ Physiol 2005; 289: H674-H682.
19. Ward JW, Forhead AJ, Wooding FB, Fowden AL. Functional significance and cortisol dependence of the gross morphology of ovine placentomes during late gestation. Biol Reprod 2006; 74:137-145.
20. Crespi EJ, Steckler TL, Mohankumar PS, Padmanabhan V. Prenatal exposure to excess testosterone modifies the developmental trajectory of the insulin-like growth factor system in female sheep. J Physiol 2006; 572: 119-130.
21. Manikkam M, Crespi EJ, Doop DD, Herkimer C, Lee JS, Yu S, Brown MB, Foster DL, Padmanabhan V. Fetal programming: Prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep. Endocrinology 2004; 145:790-798.
22. Leung ST, Reynolds TS, Wathes DC. Regulation of oxytocin receptor in the placentome capsule throughout pregnancy in the ewe: The possible role of oestradiol receptor, progesterone receptor and aromatase. J Endocrinol 1998; 158:173-181.
23. France JT, Mason JI, Magness RR, Murry BA, Rosenfeld CR. Ovine placental aromatase: Studies of activity levels, kinetic characteristics and effects of aromatase inhibitors. J Steroid Biochem 1987; 28:155-160.
24. Committee on the Nutrient Requirements of Small Ruminants NRC. Nutrient Requirements of Small Ruminants. Sheep, Goats, Cervids, and New World Camelids. Washington, DC: The National Academy Press; 2007.
25. Abbott DH, Barnett DK, Levine JE, Padmanabhan V, Dumesic DA, Jacoris S, Tarantal AF. Endocrine antecedents of polycystic ovary syndrome in fetal and infant prenatally androgenized female rhesus monkeys. Biol Reprod 2008; 79:154-163.
26. Panciera DL, MacEwen EG, Atkins CE, Bosu WT, Refsal KR, Nachreiner RF. Thyroid function tests in euthyroid dogs treated with L-thyroxine. Am J Vet Res 1990; 51:22-26.
27. Blache D, Tellam RL, Chagas LM, Blackberry MA, Vercoe PE, Martin GB. Level of nutrition affects leptin concentrations in plasma and cerebrospinal fluid in sheep. J Endocrinol 2000; 165:625-637.
28. Berrie RA, Hallford DM, Galyean ML. Effects of zinc source and level on performance and metabolic hormone concentrations of growing and finishing lambs. Prof Anim Sci 1995; 11:149-156.
29. Knight PG, Muttukrishna S, Groome NP. Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid. J Endocrinol 1996; 148:267-279.
30. O'Connor AE, McFarlane JR, Hayward S, Yohkaichiya T, Groome NP, de Kretser DM. Serum activin A and follistatin concentrations during human pregnancy: A cross-sectional and longitudinal study. Hum Reprod 1999; 14:827-832.
31. Robertson DM, Hayward S, Irby D, Jacobsen J, Clarke L, McLachlan RI, de Kretser DM. Radioimmunoassay of rat serum inhibin: Changes after PMSG stimulation and gonadectomy. Mol Cell Endocrinol 1988; 58:1-8.
32. Phillips DJ, Hedger MP, McFarlane JR, Klein R, Clarke IJ, Tilbrook AJ, Nash AD, de Kretser DM. Follistatin concentrations in male sheep increase following sham castration/castration or injection of interleukin-1 beta. J Endocrinol 1996; 151:119-124.
33. Hoaglin DC, Mosteller F, Tukey JW. Understanding Robust and Exploratory Data Analysis. New York: John Wiley & Sons, Inc.; 1983.
34. Steckler T, Wang J, Bartol FF, Roy SK, Padmanabhan V. Fetal programming: Prenatal testosterone treatment causes intrauterine growth retardation, reduces ovarian reserve and increases ovarian follicular recruitment. Endocrinology 2005; 146:3185-3193.
35. Recabarren SE, Lobos A, Figueroa Y, Padmanabhan V, Foster DL, Sir- Petermann T. Prenatal testosterone treatment alters LH and testosterone responsiveness to GnRH agonist in male sheep. Biol Res 2007; 40:329-338.
36. Shaw GM, Carmichael SL, Kaidarova Z, Harris JA. Differential risks to males and females for congenital malformations among 2.5 million California births, 1989-1997. Birth Defects Res A Clin Mol Teratol 2003; 67:953-958.
37. Tobi EW, Lumey LH, Talens RP, Kremer D, Putter H, Stein AD, Slagboom PE, Heijmans BT. DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum Mol Genet 2009; 18:4046-4053.
38. Sharpe RM, Atanassova N, McKinnell C, Parte P, Turner KJ, Fisher JS, Kerr JB, Groome NP, Macpherson S, Millar MR, Saunders PT. Abnormalities in functional development of the Sertoli cells in rats treated neonatally with diethylstilbestrol: A possible role for estrogens in Sertoli cell development. Biol Reprod 1998; 59:1084-1094.
39. Sweeney T, Nicol L, Roche JF, Brooks AN. Maternal exposure to octylphenol suppresses ovine fetal follicle-stimulating hormone secretion, testis size, and sertoli cell number. Endocrinology 2000; 141:2667-2673.
40. Recabarren SE, Rojas-Garcia PP, Recabarren MP, Alfaro VH, Smith R, Padmanabhan V, Sir-Petermann T. Prenatal testosterone excess reduces sperm count and motility. Endocrinology 2008; 149:6444-6448.
41. Purvis K, Illius AW, Haynes NB. Plasma testosterone concentrations in the ram. J Endocrinol 1974; 61:241-253.
42. Sir-Petermann T, Maliqueo M, Angel B, Lara HE, Perez-Bravo F, Recabarren SE. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: Possible implications in prenatal androgenization. Hum Reprod 2002; 17:2573-2579.
43. Weems YS, Kim L, Tsuda V, Yin C, Weems CW. What regulates placental steroidogenesis in 90-day pregnant ewes? Prostaglandins Other Lipid Mediat 2007; 84:54-65.
44. Kitawaki J, Inoue S, Tamura T, Yamamoto T, Noguchi T, Osawa Y, Okada H. Increasing aromatase cytochrome P-450 level in human placenta during pregnancy: Studied by immunohistochemistry and enzyme-linked immunosorbent assay. Endocrinology 1992; 130:2751-2757.
45. Kragie L. Aromatase in primate pregnancy: A review. Endocr Res 2002; 28:121-128.
46. Carnegie JA, Robertson HA. Conjugated and unconjugated estrogens in fetal and maternal fluids of the pregnant ewe: A possible role for estrone sulfate during early pregnancy. Biol Reprod 1978; 19:202-211.
47. Tsang CP. Changes in plasma levels of estrone sulfate and estrone in the pregnant ewe around parturition. Steroids 1974; 23:855-868.
48. Anderson H, Fogel N, Grebe SK, Singh RJ, Taylor RL, Dunaif A. Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels. J Clin Endocrinol Metab 2010; 95: 2180-2186.
49. Mindnich R, Moller G, Adamski J. The role of 17 beta-hydroxysteroid dehydrogenases. Mol Cell Endocrinol 2004; 218:7-20.
50. Bolte E, Wiqvist N, Diczfalusy E. Metabolism of dehydroepiandrosterone and dehydroepiandrosterone sulphate by the human foetus at midpregnancy. Acta Endocrinol (Copenh) 1966; 52:583-597.
51. Siiteri PK, MacDonald PC. Placental estrogen biosynthesis during human pregnancy. J Clin Endocrinol Metab 1966; 26:751-761.
52. Henson MC, Castracane VD. Leptin in pregnancy. Biol Reprod 2000; 63: 1219-1228.
53. Attal JA. Levels of testosterone, androstenedione, estrone and estradiol-17 beta in the testes of fetal sheep. Endocrinology 1969; 85:280-289.
54. Pomerantz DK, Nalbandov AV. Androgen level in the sheep fetus during gestation. Proc Soc Exp Biol Med 1975; 149:413-416.
55. Goxe B, Prunier A, Remy JJ, Salesse R. Ontogeny of gonadal luteinizing hormone and follicle-stimulating hormone receptors in the fetal pig and related changes in gonadotropin and testosterone secretion. Biol Reprod 1993; 49:609-616.
56. Finegan JA, Bartleman B, Wong PY. A window for the study of prenatal sex hormone influences on postnatal development. J Genet Psychol 1989; 150:101-112.
57. Rouiller-Fabre V, Lambrot R, Muczynski V, Coffigny H, Lecureuil C, Pairault C, Bakalska M, Courtot AM, Frydman R, Habert R. Development and regulations of testicular functions in the human foetus [in French]. Gynecol Obstet Fertil 2008; 36:898-907.
58. Cui S, Liu J, Shao Y, Zhang JC. Parallel changes between the percentage of fetal pituitary cells immunoreactive to oestrogen receptor alpha and the concentration of 17beta-oestradiol in fetal and maternal plasma during gestation in sheep. Reprod Fertil Dev 2004; 16:611-616.
59. Payen E, Pailhoux E, Abou Merhi R, Gianquinto L, Kirszenbaum M, Locatelli A, Cotinot C. Characterization of ovine SRY transcript and developmental expression of genes involved in sexual differentiation. Int J Dev Biol 1996; 40:567-575.
60. Wood CE, Gridley KE, Keller-Wood M. Biological activity of 17betaestradiol- 3-sulfate in ovine fetal plasma and uptake in fetal brain. Endocrinology 2003; 144:599-604.
61. Welt C, Sidis Y, Keutmann H, Schneyer A. Activins, inhibins, and follistatins: From endocrinology to signaling. A paradigm for the new millennium. Exp Biol Med (Maywood) 2002; 227:724-752.
62. DePaolo LV, Bicsak TA, Erickson GF, Shimasaki S, Ling N. Follistatin and activin: A potential intrinsic regulatory system within diverse tissues. Proc Soc Exp Biol Med 1991; 198:500-512.
63. Bilezikjian LM, Vale WW. Local extragonadal roles of activins. Trends Endocrinol Metab 1992; 3:218-223.
64. Phillips DJ, de Kretser DM, Hedger MP. Activin and related proteins in inflammation: Not just interested bystanders. Cytokine Growth Factor Rev 2009; 20:153-164.
65. Martins da Silva SJ, Bayne RA, Cambray N, Hartley PS, McNeilly AS, Anderson RA. Expression of activin subunits and receptors in the developing human ovary: Activin A promotes germ cell survival and proliferation before primordial follicle formation. Dev Biol 2004; 266: 334-345.
66. Wilson JD, Griffin JE, Leshin M, George FW. Role of gonadal hormones in development of the sexual phenotypes. Hum Genet 1981; 58:78-84.
67. Jones ME, Simpson ER. Oestrogens in male reproduction. Baillieres Best Pract Res Clin Endocrinol Metab 2000; 14:505-516.
68. Franks S. Adult polycystic ovary syndrome begins in childhood. Best Pract Res Clin Endocrinol Metab 2002; 16:263-272.
69. Dumesic DA, Abbott DH, Padmanabhan V. Polycystic ovary syndrome and its developmental origins. Rev Endocr Metab Disord 2007; 8:127-141.
70. Beck-Peccoz P, Padmanabhan V, Baggiani AM, Cortelazzi D, Buscaglia M, Medri G, Marconi AM, Pardi G, Beitins IZ. Maturation of hypothalamic-pituitary- gonadal function in normal human fetuses: Circulating levels of gonadotropins, their common alpha-subunit and free testosterone, and discrepancy between immunological and biological activities of circulating follicle-stimulating hormone. J Clin Endocrinol Metab 1991; 73:525-532.
71. Barbieri RL, Saltzman DH, Torday JS, Randall RW, Frigoletto FD, Ryan KJ. Elevated concentrations of the beta-subunit of human chorionic gonadotropin and testosterone in the amniotic fluid of gestations of diabetic mothers. Am J Obstet Gynecol 1986; 154:1039-1043.
72. Driscoll SG, Benirschke K, Curtis GW. Neonatal deaths among infants of diabetic mothers: Postmortem findings in ninety-five infants. Am J Dis Child 1960; 100:818-835.
73. Yildiz BO, Azziz R. The adrenal and polycystic ovary syndrome. Rev Endocr Metab Disord 2007; 8:331-342.
74. Barnes RB, Rosenfield RL, Ehrmann DA, Cara JF, Cuttler L, Levitsky LL, Rosenthal IM. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: Evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab 1994; 79:1328-1333.
75. Hickey M, Sloboda DM, Atkinson HC, Doherty DA, Franks S, Norman RJ, Newnham JP, Hart R. The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: A prospective cohort study. J Clin Endocrinol Metab 2009; 94:3714-3720.
76. Barry JA, Kay AR, Navaratnarajah R, Iqbal S, Bamfo JE, David AL, Hines M, Hardiman PJ. Umbilical vein testosterone in female infants born to mothers with polycystic ovary syndrome is elevated to male levels. J Obstet Gynaecol 2010; 30:444-446.
77. Padmanabhan V, Veiga-Lopez A, Abbott DH, Dumesic DA. Developmental programming of ovarian dysfunction. In: Gonzalez-Bulnes A (ed.), Novel Concepts in Ovarian Endocrinology. Kerala, India: Research Signpost Editors; 2007:1-24.
78. Sir-Petermann T, Codner E, Perez V, Echiburu B, Maliqueo M, Ladron de Guevara A, Preisler J, Crisosto N, Sanchez F, Cassorla F, Bhasin S. Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2009; 94:1923-1930.
79. Bukovsky A, Caudle MR, Svetlikova M, Wimalasena J, Ayala ME, Dominguez R. Oogenesis in adult mammals, including humans: A review. Endocrine 2005; 26:301-316.
80. Hartshorne GM, Lyrakou S, Hamoda H, Oloto E, Ghafari F. Oogenesis and cell death in human prenatal ovaries: What are the criteria for oocyte selection? Mol Hum Reprod 2009; 15:805-819.